Host genetics and tumour metastasis

British Journal of Cancer

Volumn 90, Issue 4, 2004, Pages 752-755

  Hunter, K W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Gene expression; Genetic background; Genetics; Inefficiency; Metastasis; Microarray; Modifiers; Mouse models; Progression; Quantitative traits

Indexed keywords

CANCER GENETICS; CANCER MORTALITY; CELL SUBPOPULATION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; METASTASIS; PRIORITY JOURNAL; SHORT SURVEY; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; ANIMAL; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MOUSE; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; TUMOR EMBOLISM;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 1642391048     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601590     Document Type: Short Survey

References (35)

1. Alessandro R, Kohn EC (2002) Signal transduction targets in invasion. Clin Exp Metastasis 19: 265-273
2. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6: 100-102
3. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MF, Fisher EM (2000) Genealogies of mouse inbred strains. Nat Genet 24: 23-25
4. Butler TP, Gullino PM (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35: 512-516
5. Domann FE, Rice JC, Hendrix MJ, Futscher BW (2000) Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85: 805-810
6. Eaves IA, Wicker LS, Ghandour G, Lyons PA, Peterson LB, Todd JA, Glynne RJ (2002) Combining mouse congenic strains and microarray gene expression analyses to study a complex trait: the NOD model of type 1 diabetes. Genome Res 12: 232-243
7. Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893-895
8. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12: 89-96
9. Guy CT, Cardiff RD, Muller WJ (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. MCB 12: 954-961
10. Heimann R, Hellman S (2000) Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol 18: 591-599
11. Heimann R, Lan F, McBride R, Hellman S (2000) Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 60: 298-304
12. Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse I, Welch DR (2001) Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brmsl. Cancer Res 61: 8866-8872
13. Hunter KW, Welch DR, Liu ET (2003) Genetic background is an important determinant of metastatic potential. Nat Genet 34: 23-24
14. Jiang S, Hemann MA, Lee MP, Feinberg AP (1998) Strain-dependent developmental relaxation of imprinting of an endogenous mouse gene, Kvlqt1. Genomics 53: 395-399
15. Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW (2003) Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 169: 1122-1133
16. Lifsted T, Le Voyer T, Williams M, Muller W, Klein-Szanto A, Buetow KH, Hunter KW (1998) Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 77: 640-644
17. Liotta LA, Stetler-Stevenson WG (1993) Principles of molecular cell biology of cancer: cancer metastasis. In Cancer: Principles & Practice of Oncology. Devita V, Hellman S, Rosenberg SA (eds). Philadelphia, PA: JB Lippincott Co
18. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865-873
19. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56
20. Muschel RJ, Williams JE, Lowy DR, Liotta LA (1985) Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am J Pathol 121: 1-8
21. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, Morris VL, Groom AC, Chambers AF (2002) Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62: 2162-2168
22. Park YG, Lukes L, Yang H, Debies MT, Samant RS, Welch DR, Lee M, Hunter KW (2002) Comparative sequence analysis in eight inbred strains of the metastasis modifier QTL candidate gene Brms1. Mamm Genome 13: 289-292
23. Qiu TH, Chandramouli GVR, Alkharouf NW, Hunter KW, Long P, Liu ET (2003) Analysis of gene expression profiles in MMTV-PyMT transgenic mice in different genomic background. (manuscript in preparation)
24. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54
25. Riethmuller G, Klein CA (2001) Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin Cancer Biol 11: 307-311
26. Rohan RM, Fernandez A, Udagawa T, Yuan J, D'Amato RJ (2000) Genetic heterogeneity of angiogenesis in mice. FASEB J 14: 871-876
27. Schirrmacher V, Fogel M, Russmann E, Bosslet K, Altevogt P, Beck L (1982) Antigenic variation in cancer metastasis: immune escape versus immune control. Cancer Metastasis Rev 1: 241-274
28. Schmidt-Kittler O, Ragg T, Daskalakis A, Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt H, Muller P, Bischoff J, Harich D, Schlimok G, Riethmuller G, Eils R, Klein CA (2003) From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 100: 7737-7742
29. Shevde LA, Welch DR (2003) Metastasis suppressor pathways - an evolving paradigm. Cancer Lett 198: 1-20
30. Steeg PS (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55-63
31. Tarin D, Price JE, Kettlewell MG, Souter RG, Vass AC, Crossley B (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 44: 3584-3592
32. Tuck AB, Wilson SM, Chambers AF (1990) Ras transfection and expression does not induce progression from tumorigenicity to metastatic abiiity in mouse LTA cells. Clin Exp Metastasis 8: 417-431
33. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536
34. Weiss L, Nannmark U, Johansson BR, Bagge U (1992) Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer 50: 103-107
35. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ, Muschel RJ (2001) Apoptosis: an early event in metastatic inefficiency. Cancer Res 61: 333-338